150 related articles for article (PubMed ID: 10910918)
1. CD3zeta and CD28 down-modulation on CD8 T cells during viral infection.
Trimble LA; Kam LW; Friedman RS; Xu Z; Lieberman J
Blood; 2000 Aug; 96(3):1021-9. PubMed ID: 10910918
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation.
Trimble LA; Shankar P; Patterson M; Daily JP; Lieberman J
J Virol; 2000 Aug; 74(16):7320-30. PubMed ID: 10906185
[TBL] [Abstract][Full Text] [Related]
3. T lymphocytes from chagasic patients are activated but lack proliferative capacity and down-regulate CD28 and CD3ζ.
Giraldo NA; Bolaños NI; Cuellar A; Roa N; Cucunubá Z; Rosas F; Velasco V; Puerta CJ; González JM
PLoS Negl Trop Dis; 2013; 7(1):e2038. PubMed ID: 23383358
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India.
Chandele A; Sewatanon J; Gunisetty S; Singla M; Onlamoon N; Akondy RS; Kissick HT; Nayak K; Reddy ES; Kalam H; Kumar D; Verma A; Panda H; Wang S; Angkasekwinai N; Pattanapanyasat K; Chokephaibulkit K; Medigeshi GR; Lodha R; Kabra S; Ahmed R; Murali-Krishna K
J Virol; 2016 Dec; 90(24):11259-11278. PubMed ID: 27707928
[TBL] [Abstract][Full Text] [Related]
5. Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.
Vingerhoets JH; Vanham GL; Kestens LL; Penne GG; Colebunders RL; Vandenbruaene MJ; Goeman J; Gigase PL; De Boer M; Ceuppens JL
Clin Exp Immunol; 1995 Jun; 100(3):425-33. PubMed ID: 7539725
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.
Hombach A; Wieczarkowiecz A; Marquardt T; Heuser C; Usai L; Pohl C; Seliger B; Abken H
J Immunol; 2001 Dec; 167(11):6123-31. PubMed ID: 11714771
[TBL] [Abstract][Full Text] [Related]
7. Signaling lymphocyte activation molecule-associated protein is a negative regulator of the CD8 T cell response in mice.
Chen G; Tai AK; Lin M; Chang F; Terhorst C; Huber BT
J Immunol; 2005 Aug; 175(4):2212-8. PubMed ID: 16081788
[TBL] [Abstract][Full Text] [Related]
8. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
9. CD11b expression identifies CD8+CD28+ T lymphocytes with phenotype and function of both naive/memory and effector cells.
Fiorentini S; Licenziati S; Alessandri G; Castelli F; Caligaris S; Bonafede M; Grassi M; Garrafa E; Balsari A; Turano A; Caruso A
J Immunol; 2001 Jan; 166(2):900-7. PubMed ID: 11145666
[TBL] [Abstract][Full Text] [Related]
10. Large clonal expansions of human virus-specific memory cytotoxic T lymphocytes within the CD57+ CD28- CD8+ T-cell population.
Weekes MP; Wills MR; Mynard K; Hicks R; Sissons JG; Carmichael AJ
Immunology; 1999 Nov; 98(3):443-9. PubMed ID: 10583606
[TBL] [Abstract][Full Text] [Related]
11. Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells.
Makedonas G; Hutnick N; Haney D; Amick AC; Gardner J; Cosma G; Hersperger AR; Dolfi D; Wherry EJ; Ferrari G; Betts MR
PLoS Pathog; 2010 Mar; 6(3):e1000798. PubMed ID: 20221423
[TBL] [Abstract][Full Text] [Related]
12. A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3zeta-CD28 signalling targets T cells from colorectal cancer patients against their tumour cells.
Hombach A; Schlimper C; Sievers E; Frank S; Schild HH; Sauerbruch T; Schmidt-Wolf IG; Abken H
Gut; 2006 Aug; 55(8):1156-64. PubMed ID: 16188919
[TBL] [Abstract][Full Text] [Related]
13. Human CD28-CD8+ T cells contain greatly expanded functional virus-specific memory CTL clones.
Weekes MP; Carmichael AJ; Wills MR; Mynard K; Sissons JG
J Immunol; 1999 Jun; 162(12):7569-77. PubMed ID: 10358214
[TBL] [Abstract][Full Text] [Related]
14. 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.
Zhang H; Snyder KM; Suhoski MM; Maus MV; Kapoor V; June CH; Mackall CL
J Immunol; 2007 Oct; 179(7):4910-8. PubMed ID: 17878391
[TBL] [Abstract][Full Text] [Related]
15. Expansion of cytotoxic CD8+ CD28- T cells in healthy ageing people, including centenarians.
Fagnoni FF; Vescovini R; Mazzola M; Bologna G; Nigro E; Lavagetto G; Franceschi C; Passeri M; Sansoni P
Immunology; 1996 Aug; 88(4):501-7. PubMed ID: 8881749
[TBL] [Abstract][Full Text] [Related]
16. CD8+ T cell subsets of cytotoxic T lymphocytes induced by Epstein-Barr virus infection in infectious mononucleosis.
Ebihara T; Sakai N; Koyama S
Tohoku J Exp Med; 1990 Nov; 162(3):213-24. PubMed ID: 1965352
[TBL] [Abstract][Full Text] [Related]
17. CD8
Nandi M; Pal S; Ghosh S; Chakraborty BC; Dey D; Baidya A; Shil A; Chattopadhyaya S; Banerjee S; Santra A; Chowdhury A; Datta S
Clin Sci (Lond); 2019 Sep; 133(17):1917-1934. PubMed ID: 31477625
[TBL] [Abstract][Full Text] [Related]
18. Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic.
Zhang D; Shankar P; Xu Z; Harnisch B; Chen G; Lange C; Lee SJ; Valdez H; Lederman MM; Lieberman J
Blood; 2003 Jan; 101(1):226-35. PubMed ID: 12393740
[TBL] [Abstract][Full Text] [Related]
19. CD3xCD19 bispecific antibodies and CD28 bivalent antibodies enhance T-cell reactivity against autologous leukemic cells in pediatric B-ALL bone marrow.
Manzke O; Berthold F; Huebel K; Tesch H; Diehl V; Bohlen H
Int J Cancer; 1999 Mar; 80(5):715-22. PubMed ID: 10048973
[TBL] [Abstract][Full Text] [Related]
20. The phenotype of type 1 and type 2 CD8+ T cells activated in vitro is affected by culture conditions and correlates with effector activity.
Kemp RA; Bäckström BT; Ronchese F
Immunology; 2005 Jul; 115(3):315-24. PubMed ID: 15946249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
